We are live on ! Find out more
PVLA

Palvella Therapeutics
PVLA

105 hedge funds and large institutions have $199M invested in Palvella Therapeutics in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 29 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

31% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 29

11% more capital invested

Capital invested by funds: $179M → $199M (+$20.4M)

0.01% more ownership

Funds ownership: 0.82% → 0.82% (+0.01%)

9% less funds holding

Funds holding: 115 → 105 (-10)

45% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 22

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $363K

Holders
105
Holders Change
-10
Holders Change %
-8.7%
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
12
Increased
38
Reduced
29
Closed
22
Calls
–
Puts
$363K
Net Calls
-$363K
Net Calls Change
+$122K

Top Buyers

1
NCM
Nantahala Capital Management
Connecticut
+$3.45M
2
Millennium Management
Millennium Management
New York
+$3.38M
3
PM
Prosight Management
Texas
+$1.64M
4
BI
BVF Inc
California
+$1.38M
5
PAWC
P.A.W. Capital
Connecticut
+$1.36M

Top Sellers

1
O
OrbiMed
New York
-$3.72M
2
SSA
Schonfeld Strategic Advisors
New York
-$2.33M
3
OAM
Oxford Asset Management
United Kingdom
-$1.26M
4
BIM
Bogle Investment Management
Massachusetts
-$904K
5
LOAMU
Lombard Odier Asset Management (USA)
New York
-$857K
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
101
Truvestments Capital
Florida
$8K +$8.26K +19 New
PNC Financial Services Group
102
PNC Financial Services Group
Pennsylvania
$6K – – –
Royal Bank of Canada
103
Royal Bank of Canada
Ontario, Canada
$6K +$4.78K +11 +550%
LTFS
104
Ladenburg Thalmann Financial Services
Florida
$3K – – –
Bank of Montreal
105
Bank of Montreal
Ontario, Canada
$2K -$435 -1 -20%
MWNA
106
Marshall Wace North America
New York
– -$816K -2,011 Closed
AIM
107
Alambic Investment Management
California
– -$406K -1,001 Closed
AIA
108
Affinity Investment Advisors
California
– -$308K -759 Closed
Jacobs Levy Equity Management
109
Jacobs Levy Equity Management
New Jersey
– -$215K -531 Closed
California Public Employees Retirement System
110
California Public Employees Retirement System
California
– -$179K -441 Closed
PCM
111
Piermont Capital Management
Missouri
– -$178K -439 Closed
CSS
112
Cubist Systematic Strategies
Connecticut
– -$160K -393 Closed
BPM
113
Bowling Portfolio Management
Ohio
– -$156K -385 Closed
Squarepoint
114
Squarepoint
New York
– -$143K -354 Closed
FRM
115
Fox Run Management
Connecticut
– -$124K -306 Closed
Two Sigma Investments
116
Two Sigma Investments
New York
– -$121K -298 Closed
Ohio Public Employees Retirement System (OPERS)
117
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$110K -271 Closed
Balyasny Asset Management
118
Balyasny Asset Management
Illinois
– -$85K -210 Closed
Commonwealth Equity Services
119
Commonwealth Equity Services
Massachusetts
– -$82K -201 Closed
WJA
120
Williams Jones & Associates
New York
– -$71K -175 Closed
CS
121
Credit Suisse
Switzerland
– -$69K -171 Closed
Parallax Volatility Advisers
122
Parallax Volatility Advisers
California
– -$59K -145 Closed
JT
123
Jump Trading
Illinois
– -$51K -126 Closed
Russell Investments Group
124
Russell Investments Group
United Kingdom
– -$31K -76 Closed
PIA
125
Piedmont Investment Advisors
North Carolina
– -$5K -11 Closed
2 3 4
5
6

PVLA Hedge Fund Activity: Q3 2018 in Review

105 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q3 2018, worth a combined $199M — up 11% from $179M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of PVLA and 12 opened new positions — a net loss of 10 holders — while 29 trimmed existing stakes and 38 added.

The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $3.45M. The largest seller was OrbiMed, cutting an estimated $3.72M.

  • 105 institutional investors held Palvella Therapeutics (PVLA) as of Q3 2018, down from 115 in Q2 2018.
  • Funds reported $199M of Palvella Therapeutics stock for Q3 2018, up 11% quarter-over-quarter.
  • 12 funds opened new Palvella Therapeutics positions in Q3 2018 and 22 closed out, a net change of -10 holders.
  • The largest Palvella Therapeutics buyer in Q3 2018 was Nantahala Capital Management, an estimated $3.45M added.
  • The largest Palvella Therapeutics seller in Q3 2018 was OrbiMed, an estimated $3.72M sold.

Based on aggregated 13F filings for Q3 2018.